CRP and cancer: High levels of biomarkers associated with inflammation (C-reactive protein, CRP, and IL-6) and coagulopathy (D-dimer and fibrinogen) are associated with increased risk of cardiovascular disease [77-80], increased cancer risks [81-83] and mortality [80,84-86] in the general population.